🚧 Under construction — VoTechWorks is being built. A free tech program — complimentary, as our commitment to get America working.
voTechWorksGrade 13 · a vocational technology learning center, by urbanicity
newSchoolWorks.com › VoTechWorks › Health & Personal Services › Respiratory Therapy › Oxygen Therapy › Lesson 11
HLT-RESP80-04 · Lesson 11 · 36 clock hours · practice

Titration, Weaning, and Discontinuation of Oxygen Therapy

Objective. Given a series of clinical scenarios, the student will follow a structured protocol to titrate, wean, and discontinue supplemental oxygen therapy while monitoring for patient deterioration and documenting each decision step.

⚠ Pending professional review

This lesson, its worked examples and its practice questions has not yet been verified by a licensed clinician in the field or by a certification or approval body. It is a study draft and may contain errors. Do not use it to make decisions about any patient or medication. Always follow your instructor, your supervising professional, and current official references and regulations.

VoTechWorks program approval and accreditation are still in progress. Credentials are issued only by the certifying bodies named in each program, after their own exams.

Titration, Weaning, and Discontinuation of Oxygen Therapy

Supplemental oxygen is a drug. Like any drug, it must be given at the right dose, adjusted as the patient's condition changes, and stopped when it is no longer needed. This lesson walks through a structured approach to titrating, weaning, and discontinuing oxygen therapy safely.

Why Titration Matters

Both hypoxemia and hyperoxia carry risks. Untreated hypoxemia causes tissue injury and organ failure. Excessive oxygen can worsen outcomes in patients recovering from certain conditions, including some patients with chronic obstructive pulmonary disease (COPD) who depend partly on a hypoxic drive, and in neonates where hyperoxia is linked to retinopathy. Current evidence supports targeting a specific SpO2 range rather than simply administering the highest tolerated flow. For most hospitalized adults, a commonly accepted target is SpO2 88–92% in patients at risk of hypercapnia (e.g., COPD exacerbation) and 94–98% for patients without that risk. Always follow the ordering provider's written order and your facility protocol.

The Titration Process

Titration means adjusting the oxygen flow rate or device to keep the patient within the target SpO2 range.

Starting point: Confirm the ordered target range and current baseline. Assess the patient: level of consciousness, work of breathing, respiratory rate, heart rate, skin color, and SpO2.

Upward titration (increasing O2): If SpO2 falls below the lower limit of the target range, increase flow in small increments — typically 1–2 L/min on a nasal cannula — and reassess within a few minutes. If the patient deteriorates rapidly, escalate to a higher-acuity delivery device (simple mask, non-rebreather, high-flow nasal cannula) and notify the provider immediately.

Downward titration (weaning): If SpO2 is consistently at or above the upper limit of the target range, reduce flow in small steps. After each reduction, allow adequate time (at least 5–10 minutes at rest; longer with activity or sleep) before reassessing. Decreasing flow while the patient is asleep or during ambulation requires extra vigilance because SpO2 may drop with positional change or increased demand.

Evidence-Based Protocols

Many facilities use a nurse- or therapist-driven protocol so that weaning can begin without waiting for a new physician order each time. These protocols specify:

When reading any protocol, identify its decision points: the specific numeric thresholds that drive each action. A flowchart is a useful tool for visualizing these branch points.

Weaning Steps in Practice

1. Verify the patient is clinically stable: no increased work of breathing, no new complaints of dyspnea, heart rate within normal limits.

2. Reduce flow by the smallest practical increment for the device in use.

3. Reassess SpO2 and clinical signs after an appropriate interval.

4. If stable within target range, continue monitoring and prepare for the next reduction or for discontinuation.

5. If SpO2 drops below the lower target threshold, return to the previous flow setting and document.

6. If the patient cannot maintain SpO2 despite return to prior settings, escalate and notify the provider.

Discontinuation Criteria

Oxygen therapy may be discontinued when the patient maintains SpO2 within the target range on room air at rest, with activity, and (for inpatients) during sleep if applicable. Key criteria often include:

For home oxygen patients, discontinuation requires a formal reassessment — usually at 60–90 days post-discharge — demonstrating that the patient no longer meets qualification criteria on room air at rest and with exertion. Discontinuation of home oxygen must be documented and communicated to the prescribing provider.

Documentation Requirements

Every change must be recorded: date, time, flow rate before and after adjustment, device used, SpO2 and other vital signs, patient response, and your clinical reasoning. Accurate documentation protects the patient, supports continuity of care, and satisfies legal and licensing requirements. A therapy flow sheet is the standard tool in most acute care settings.

Safety Points

Key terms10

TitrationThe incremental adjustment of oxygen flow rate or delivery device to maintain the patient's SpO2 within a prescribed target range.
SpO2Peripheral oxygen saturation measured by pulse oximetry; expressed as a percentage and used to guide oxygen dosing decisions.
WeaningThe gradual, stepwise reduction of supplemental oxygen as the patient's clinical status improves, with ongoing monitoring at each step.
Hypoxic DriveA physiologic mechanism in some patients with chronic hypercapnia in which low PaO2 — rather than elevated CO2 — serves as the primary stimulus to breathe; relevant when setting O2 targets in COPD.
Therapist-Driven Protocol (TDP)A written, physician-approved standing order that authorizes the respiratory therapist to initiate, adjust, or discontinue oxygen therapy based on defined clinical criteria without a separate order for each change.
Target SpO2 RangeThe ordered upper and lower SpO2 values between which therapy is adjusted; varies by patient diagnosis and risk factors.
Critical DesaturationA sudden or severe drop in SpO2 below an acceptable threshold that requires immediate intervention, escalation of oxygen delivery, and provider notification.
Discontinuation CriteriaThe clinical benchmarks — typically sustained SpO2 on room air at rest and with activity above the lower target limit — that must be met before supplemental oxygen is stopped.
HyperoxiaAn excess of oxygen in tissues or blood resulting from too-high FiO2; associated with adverse outcomes including worsening ventilation-perfusion mismatch and oxidative injury.
Therapy Flow SheetA standardized documentation form used to record all oxygen therapy changes, SpO2 values, clinical signs, and therapist decisions across a patient's treatment course.
In class: Protocol analysis exercise: students read two evidence-based oxygen titration protocols (one for acute care, one for home/subacute) and create a flowchart summarizing decision points and triggers. · Simulation-based weaning drill: using a high-fidelity or task-trainer manikin with adjustable SpO2 output, students titrate flow in response to instructor-controlled SpO2 and clinical sign changes, documenting each change on a therapy flow sheet. · Written case debrief: students review a completed case (initial presentation through weaning and discharge) and write a one-page clinical narrative justifying each oxygen therapy decision, referencing the relevant guideline.
Materials: Simulation manikin with SpO2 control or task trainer, SpO2 monitor, oxygen delivery devices, therapy flow sheets, printed protocols, clinical case packet, Egan's Fundamentals (oxygen weaning section)
Check: Simulation performance scored on titration checklist; pass mark 80% with zero errors in recognizing and responding to a simulated critical desaturation event; written case narrative graded on a rubric at 75%.

Practice check8

Answer each question, then check it. Nothing is recorded; this is your own practice.

Evaluate and Monitor Patient Outcome
1. A patient with a COPD exacerbation has an SpO2 of 95% on 4 L/min nasal cannula. The therapist-driven protocol targets SpO2 88–92%. What is the most appropriate first action?
Initiate, Conduct, and Modify Prescribed Therapeutic Procedures
2. During a weaning trial, the patient's SpO2 drops from 91% to 83% within two minutes of a flow reduction. What should the respiratory therapist do first?
Evaluate and Monitor Patient Outcome
3. Which finding would most support discontinuing supplemental oxygen in a hospitalized patient?
Initiate, Conduct, and Modify Prescribed Therapeutic Procedures
4. A therapist-driven protocol authorizes the RT to reduce nasal cannula flow by 1 L/min when SpO2 remains above the upper target limit for at least 30 minutes. A patient's SpO2 has been 97% for 45 minutes on 3 L/min; the target is 94–98%. What action is indicated?
Communication and Documentation
5. When documenting an oxygen flow reduction on a therapy flow sheet, which information is essential to include?
Evaluate and Monitor Patient Outcome
6. A home oxygen patient is reassessed 60 days after hospital discharge. On room air her SpO2 is 95% at rest and 93% with a six-minute walk. She has no dyspnea. What is the appropriate recommendation?
Select, Assemble, and Check Equipment
7. A nasal cannula is running at 6 L/min but the patient's SpO2 remains at 87%, below the target of 92–95%. What is the correct next step?
Apply Scientific Principles to Patient Care
8. Which patient population requires particular caution to avoid hyperoxia during oxygen titration, due to the risk of suppressing ventilatory drive?
Record this lesson on my transcript. Sign in with your key and enrollment email to record lessons (enroll free if you have no key). This page stays open to read and practise.